AI assistant
Sending…
NEPHROS INC — Director's Dealing 2025
Nov 13, 2025
34594_dirs_2025-11-13_3571ebea-1af0-46f2-b336-171b30c6c774.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEPHROS INC (NEPH)
CIK: 0001196298
Period of Report: 2025-11-10
Reporting Person: Nettis Lisa Marie (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-10 | Common Stock | A | 1622 | — | Acquired | 1622 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $4.49 | 2035-08-11 | Common Stock (13229) | 13229 | Direct |
Footnotes
F1: This option vests as to 4,410 shares on each of 6/16/25 and 6/16/26 and 4,409 options vest on 6/16/27.
More from NEPHROS INC
Regulatory Filings
2026
May 7
Regulatory Filings
2025
Nov 26
Major Shareholding Notification
2025
Nov 14
Director's Dealing
2025
Nov 13
Director's Dealing
2025
Nov 13
Interim / Quarterly Report
2025
Nov 6
Director's Dealing
2025
Aug 13
Regulatory Filings
2025
Aug 11
Interim / Quarterly Report
2025
Aug 7
Director's Dealing
2025
Jul 11